ArticleFrontiers in plant science2016
Early Selection for Smut Resistance in Sugarcane Using Pathogen Proliferation and Changes in Physiological and Biochemical Indices.
Article in Frontiers in plant science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 67 citations in OpenAlex.
- Revisiting the Molecular Roadmap for Sugar Crops: Genome Reading, Trait Writing and Variety Redesigning.Plant biotechnology journal · 2026Review
- Isolationand Identification of Antagonistic Bacteria AgainstPlants (Basel, Switzerland) · 2026Article
- Auxin dysregulation: a key early event in sugarcane susceptibility to Sporisorium scitamineum.BMC plant biology · 2026Article
- Article
- ScWRKY2: a key regulator for smut resistance in sugarcane.Plant biotechnology journal · 2025Article
- Interference with sexual mating ofMycology · 2025Article
- Two SugarcaneJournal of fungi (Basel, Switzerland) · 2024Article
- Screening of sugarcane germplasm against Sporisorium scitamineum and its effects on setts germination and tillering.Scientific reports · 2024Article
- Comparative Analysis of Sucrose-Regulatory Genes in High- and Low-Sucrose Sister Clones of Sugarcane.Plants (Basel, Switzerland) · 2024Article
- An efficient inoculation method to evaluate virulence differentiation of field strains of sugarcane smut fungus.Frontiers in microbiology · 2024Article
- Genome-Wide Identification, Characterization, and Expression Analysis of Glutamate Receptor-like Gene (Plants (Basel, Switzerland) · 2022Article
- Identification of Gene Modules and Hub Genes Associated withJournal of fungi (Basel, Switzerland) · 2022Article
- Effect of Smut Infection on the Photosynthetic Physiological Characteristics and Related Defense Enzymes of Sugarcane.Life (Basel, Switzerland) · 2022Article
- A Plant-Derived Alkanol Induces Teliospore Germination inJournal of fungi (Basel, Switzerland) · 2022Article
- Genome-wide identification and expression analysis of the coronatine-insensitive 1 (COI1) gene family in response to biotic and abiotic stresses in Saccharum.BMC genomics · 2022Article
- Sugarcane Smut: Current Knowledge and the Way Forward for Management.Journal of fungi (Basel, Switzerland) · 2021Review
- Comparative expression analysis of potential pathogenicity-associated genes of high- and low-virulent3 Biotech · 2021Article
- Novel approaches to circumvent the devastating effects of pests on sugarcane.Scientific reports · 2021Article
- Detection of a major QTL related to smut disease resistance inherited from a Japanese wild sugarcane using GRAS-Di technology.Breeding science · 2021Article
- A class III WRKY transcription factor in sugarcane was involved in biotic and abiotic stress responses.Scientific reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sugarcane smut disease, caused by Sporisorium scitamineum, significantly decreases yield and use of resistant cultivars is the most cost-effective measure for disease control. Current field testing methods for identification of smut resistance are time-consuming and hindered by environmental variability. Our goal was to develop an efficient and reliable resistance identification technique that is rapid, performed in a controlled environment, and stable. Nine sugarcane cultivars with different phenotypic resistance levels were selected. TaqMan quantitative real-time polymerase chain reaction analysis was performed to measure copy number changes of smut pathogen in sugarcane buds at 0-7 days after needle puncture inoculation. There was a positive correlation between time after inoculation and the amount of smut pathogen in the sugarcane bud. This reached a peak value on 7 days, and the copy number of S. scitamineum increased in the following order: YZ03-258, FN40, YZ01-1413, GT02-467, ROC22, YT96-86, YZ03-103, FN39, LC05-136. After smut pathogen inoculation, differences in the physiological and biochemical indices of the nine cultivars were observed. Peroxidase, ascorbate peroxidase, catalase, superoxide dismutase, β-1,3-glucanase, and malondialdehyde were grouped into three main components, and the cumulative contribution rate was 80.177%, revealing that these are useful physiological and biochemical indicators of smut resistance. Subordinate function analysis indicated that the levels of smut resistance of the nine genotypes were (high to low): YZ03-258, FN40, YZ01-1413, GT02-467, ROC22, YZ03-103, YT96-86, FN39, LC05-136, which is similar to the results from copy number determination of smut pathogens. The results suggest that after artificial needle inoculation, rapid identification of physiological resistance to sugarcane smut was achieved based on copy number increases in the sugarcane smut pathogen and the physiological and biochemical changes in sugarcane bud during the early phase of infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.